News | November 15, 2025
Aurobindo Pharma gets 9 observations from USFDA for Unit 2 of Eugia Pharma Specialities
The observations are procedural in nature and will be responded to within the stipulated time
The observations are procedural in nature and will be responded to within the stipulated time
Nearly 1 in 3 HbA1c test results fall within the diabetic range, while 1 in 4 individuals show signs of prediabetes
False positive rates?ranged from 0% to 41%, meaning some labs incorrectly identified bacteria that weren’t present in the sample
Poviztra is a second brand of Wegovy
Sun Pharmaceutical Industries has reported total income of Rs. 14,948.23 crore during the period ended September 30, 2025
The expanded approval allows Kerendia to be prescribed to heart failure patients with a LVEF of 40% or more
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
Dabur India has reported total income of Rs. 3,331.45 crore during the period ended September 30, 2025
Indraprastha Medical Corporation has reported total income of Rs. 388.40 crore during the period ended September 30, 2025
PET sheets are widely recognised for their superior clarity, strength, and barrier properties
Subscribe To Our Newsletter & Stay Updated
